Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

The impact of the COVID-19 pandemic on the use of restraint and seclusion interventions in Ontario emergency departments: A population-based study

  • Meghan Weissflog ,

    Roles Conceptualization, Data curation, Formal analysis, Methodology, Visualization, Writing – original draft, Writing – review & editing

    mweissflog@waypointcentre.ca (MW); nathan.kolla@camh.ca (NJK)

    Affiliation Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada

  • Soyeon Kim,

    Roles Methodology, Writing – review & editing

    Affiliations Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada

  • Natalie Rajack,

    Roles Data curation, Writing – review & editing

    Affiliation Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada

  • Nathan J. Kolla

    Roles Conceptualization, Methodology, Project administration, Supervision, Writing – review & editing

    mweissflog@waypointcentre.ca (MW); nathan.kolla@camh.ca (NJK)

    Affiliations Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, Ontario, Canada, Forensic Psychiatry Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada, Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Abstract

While COVID-19 impacted all aspects of health care and patient treatment, particularly for patients with mental health/substance use (MH/SU) concerns, research has suggested a concerning increase in the use of restraint and seclusion (R/S) interventions, although results vary depending on facility type and patient population. Thus, the present study sought to explore COVID-related changes in the use of R/S interventions among patients presenting to Ontario emergency departments (EDs) with MH/SU complaints. To determine whether temporal and clinical factors were associated with changes in R/S use during COVID, binary logistic regression models were computed using data from the National Ambulatory Care Reporting System database. We then compared both prevalence rates and probability of an R/S event occurring during an ED visit in Ontario before and after the onset of COVID. The number of ED visits during which an R/S event occurred for patients presenting with MH/SU concerns increased by 9.5%, while their odds of an R/S event occurring during an ED visit increased by 23% in Ontario after COVID onset. Similarly, R/S event probability increased for patients presenting with MH/SU concerns after COVID onset (0.7% - 21.3% increase), particularly during the first wave, with the greatest increases observed for concerns associated with increased restraint risk pre-COVID. R/S intervention use increased substantially for patients presenting to Ontario EDs with MH/SU concerns during the first wave of COVID when the strain on healthcare system and uncertainty about the virus was arguably greatest. Patients with concerns already associated with increased R/S risk also showed the largest increases in R/S probability, suggesting increased behavioural issues during treatment among this population after COVID onset. These results have the potential to inform existing policies to mitigate risks associated with R/S intervention use during future public health emergencies and in general practice.

Introduction

In line with the global response to the emergence of the novel coronavirus 2019 (COVID-19), the Ontario Provincial Government declared COVID to be a Public Health Emergency on March 17, 2020 [1]. Predictably, the implementation of a number of public health measures to reduce the spread of infection greatly impacted the Ontario healthcare system [26], which, in turn, greatly impacted patient treatment options and experiences [79]. Emergency departments (EDs), in particular, saw a substantial decrease in the number of patients accessing emergency services, largely due to public health restrictions and fears of COVID exposure in hospital settings [4, 1012]. This hesitancy to access emergency services had a disproportionate effect on already vulnerable and underserved patient populations during the pandemic, namely those suffering from mental health and/or substance use (MH/SU)-related disorders, for whom emergency services were a primary source of assistance for some prior to the COVID pandemic [1315]. Of particular concern, research into the impact of COVID on emergency service provision has shown a significant reduction in both psychiatric care and substance use treatment resources during the pandemic [9, 1618] despite the notable increase in MH/SU-related concerns during this time [1926].

In light of the observed reduction in both emergency and psychiatric service access due to the COVID pandemic, one aspect of patient treatment that deserves further exploration is whether the pandemic also impacted the use of restraint and seclusion (R/S) interventions amongst patients during service provision in emergency care facilities. The impact of COVID on the use of R/S interventions during treatment is of concern for a number of reasons, including the fact that COVID was an unprecedented event that affected service provision at every level of the healthcare system [26]. Given the fact that the frequency of R/S intervention use is considered an indicator of the quality of care [2730], due to the very real potential for physical (e.g., asphyxiation, fractures, muscle atrophy and contracture, etc.) and psychological injury (e.g., agitation, delirium, PTSD, etc.) [31, 32], understanding how R/S use was impacted by the pandemic offers a useful measure of the broader impact of COVID on health care system and patient experiences.

Existing research on COVID-related changes in R/S intervention use is in its early stages, with reported changes in R/S use varying substantially depending on the patient population and hospital setting. For example, a study from a tertiary mental health hospital in Ontario, Canada [33] noted a substantial reduction (49–100%) in the use of mechanical restraints in adolescent, forensic, and geriatric patient programs after the implementation of COVID-related restrictions. However, they only sampled data for the first 6 weeks after the COVID onset. Similarly, a high-needs psychiatric ward in Dublin, Ireland [34] reported substantial reductions in the use of R/S interventions after voluntarily reducing ward occupancy to facilitate social distancing and other infection prevention strategies. Specifically, reducing bed availability by only 5% resulted in the number of R/S events decreasing by more than 50% over nine months following the onset of the COVID pandemic. On the other hand, research from a mental health hospital in Malaga, Spain, found no change in the likelihood of mechanical restraint [35].

Most consistently, though, researchers have reported increased use of R/S interventions after the onset of the COVID pandemic. For example, a substantial increase in the incidence rate of physical restraint use was observed in geriatric dementia patients presenting to an acute care hospital in Japan, reaching a 50% likelihood of a restraint event approximately four months after the enactment of nationwide public health measures [36]. Similarly, orders for physical restraint interventions among older adults during acute care hospitalization in Ontario, Canada, were found to have increased in prevalence by 2.4% [37], while children and youth presenting with mental health concerns to a pediatric hospital in Michigan, USA were found to be almost four times more likely to experience a restraint event after the onset of the COVID pandemic [38]. A retrospective study on youth and adolescent psychiatric hospitalizations in Israel also noted a small increase in R/S intervention use despite a significant decrease in the number of admissions after the onset of COVID [39]. Similarly, a study of adult psychiatric admissions in Germany found that the number R/S events increased by almost 25% for patients who were voluntarily admitted, and 13% among those who were involuntarily admitted during the pandemic [40]. Finally, a study from the Department of Psychiatry at the Geneva University Hospital in Switzerland reported a slight increase in the number of seclusion events after COVID onset, despite a decrease in both voluntary and involuntary hospital admissions [41].

Current study

With few exceptions, the emerging research described above suggests that the use of R/S interventions increased after the onset of the COVID pandemic, although the degree to which R/S use changed appears to depend on a number of factors, including facility type, patient population, and the institution of COVID-related public health policies and restrictions. However, it is currently unknown whether R/S intervention use changed in other clinical settings, such as EDs, which saw dramatic changes in service provision during the pandemic [4, 1012]. Similarly, existing research has focused solely on R/S use for patients with MH issues [3341], despite the fact that SU-related concerns increased on par with MH-related concerns during the pandemic [1926] and are a known risk factor for the use of R/S interventions [42, 43].

As such, the purpose of the present study was to explore whether specific temporal and clinical case factors were associated with changes in the likelihood of experiencing an R/S event among patients presenting to Ontario EDs with MH/SU-related complaints after the onset of the COVID pandemic. In light of the fact that the frequency of R/S events is a useful indicator of both quality of care and patient experience [2730], understanding how the onset of the pandemic affected the use of R/S interventions offers important insight into the broader impact of COVID among MH/SU patients seeking emergency care. To this end, the current study employed data from the National Ambulatory Care Reporting System (NACRS) [44] to compare both the prevalence rate and probability of an R/S event occurring during an ED visit before and after the onset of COVID to determine if specific temporal and clinical factors were associated with changes in the probability of using R/S interventions.

Materials and methods

Sample

Data for this study were obtained from the NACRS database of emergency care service provision across Canada on November 10, 2021. The raw dataset consisted of administrative and clinical data from 559,817 separate ED visits in Ontario during the fiscal years 2019 (N = 298,734) and 2020 (N = 261,083). These data are anonymized by CIHI prior to dissemination and do not contain information by which an individual accessing ED services could be personally identified.

Due to the nature of the present study, we limited our sample to cases with complete data regarding R/S intervention use. The availability of this data is subject to the data collection instructions set out by NACRS [45], which mandate reporting of R/S intervention use data only for ED patients presenting with a main problem diagnosis (see Clinical Variables below) from the Mental and Behavioural Disorders (Chapter V) or Intentional Self-Harm categories of the ICD-10-CA [46, 47], regardless of whether an R/S even occurred. Thus, to ensure complete R/S use data, we restricted our sample to cases in which an individual presented to an Ontario ED with an MH/SU-related primary concern for the present analyses, resulting in a final sample of data for 332,046 individual ED visits (2019: N = 174,686 cases; 2020: N = 157,360 cases; Table 1).

thumbnail
Table 1. Sample descriptives for clinical and temporal variables of interest for ED visits in Ontario during the 2019 and 2020 fiscal years.

https://doi.org/10.1371/journal.pone.0302164.t001

Study measurements

Occurrence of R/S intervention event.

The use of any R/S intervention is documented in the NACRS database by the type and duration of the intervention that was used. We derived a binary variable indicating whether or not an R/S event had occurred during each recorded visit in the dataset by taking the type of R/S intervention used and recoding all R/S intervention types as "1", indicating that an R/S event had occurred during that visit, while all instances of "none" were recoded to "0", indicating that no R/S event occurred.

Type of R/S intervention event.

We also derived a categorical variable to indicate which type of R/S intervention occurred during each recorded visit in the dataset. We took the type of intervention and recoded all R/S interventions ((1) No R/S intervention, (2) physical restraint, (3) mechanical restraint, (4) chair restraint, or (5) seclusion room) into one of three categories ("0" = no R/S intervention, "1" = restraint, "2" = seclusion).

Registration year.

The data used in the present analyses consisted of client visit data collected at the time of service provision at ED rooms across Ontario, Canada, during either the (1) 2019 and (2) 2020 fiscal year (April 1 –March 31). We chose to focus on this time range because it naturally overlapped with the declaration of COVID as a public health emergency in Ontario in March 2020.

Registration month.

The registration month was coded from the date on which the patient officially registered for service provision in an Ontario ED, resulting in twelve categories, one for each month of the year. Because the present data are split based on fiscal and not calendar year, an anomaly exists in the sense that March "2019" was, in actuality, March 2020, the beginning of the COVID public health emergency in Ontario. Thus, we excluded the month of March from later interpretations to avoid an inaccurate representation of the time prior to COVID onset.

Main Problem Diagnosis (MPDx).

Patients presenting at EDs in Ontario are assigned an ICD-10-CA code that best describes the most clinically significant reason for the visit (e.g., requiring the greatest use of resources), as judged by the attending physician. As noted above, due to the reporting criteria for R/S interventions in Ontario EDs we limited our sample to patients with an MPDx of MH/SU (ICD-10 Mental Health and Behavioural Disorders), divided into ten separate diagnostic categories: (1) alcohol abuse (F100-F109), (2) opioid abuse (F110-F119), (3) cannabinoid abuse (F120-129), (4) multiple drug abuse (F130-199), (5) dementia (F010-F019; F03), (6) psychotic disorders (F20-F29), (7) mood disorders (F30-F39), (8) neurotic (anxiety) disorders (F40-F48), (9) other mental health disorders (F50-F59), (10) personality disorders (F60-69).

Data analyses

To examine COVID-related changes in R/S in Ontario EDs among patients with MH/SU presentations, we calculated percent change scores between cases before (2019) and after (2020) COVID onset for the number of ED visits, the occurrence of an R/S event and the type of R/S event per visit. In addition, an unadjusted binary logistic regression analysis was conducted predicting the occurrence of an R/S event (yes/no) from the registration year (2019/2020) to determine whether any observed changes in R/S prevalence corresponded to a significant change in the odds of experiencing an R/S event after COVID onset.

We then examined the association of temporal (registration month) and administrative factors (MH/SU MPDx) with changes in R/S intervention use after COVID onset by conducting a series of unadjusted binary regression analyses predicting R/S event occurrence (yes/no) from registration year (2019/2020), entering each factor as a moderator of this relationship (S1 Table). From the resulting regression models, we derived the probability of experiencing an R/S event for each category of the predictor variables in both 2019 and 2020 and calculated the percentage change in probability before and after the COVID onset (S2 Table). We chose to present probability statistics in the present study, as opposed to the more traditional odds ratio (OR) statistics associated with binary logistic regression analyses, due to the fact that ORs, by definition, are derived based on a reference group. In the case of the present data, there is no natural control or reference group/category, making any relative comparisons between predictor categories arbitrary and the results difficult to generalize. All analyses were conducted using SPSS (v.28) [48] and Microsoft Excel (2016) [49].

Results

COVID-related changes in ED visits and the use of R/S interventions

Before exploring factors associated with COVID-related changes in R/S intervention use, we first wanted to determine that there were, in fact, significant changes in the number of ED visits and/or the number of R/S events that occurred in Ontario EDs after the onset of COVID. The overall number of visits to Ontario EDs for MH/SU presentations decreased by 9.9% (17,326 visits) after the onset of the pandemic (Table 1 and Fig 1).

thumbnail
Fig 1. Number of ED visits by registration year.

Number of ED visits in Ontario for MH/SU concerns before (2019) and after (2020) the onset of the COVID-19 pandemic. ED = emergency department, MH/SU = mental health/substance use.

https://doi.org/10.1371/journal.pone.0302164.g001

While ED visits decreased in general, the number of visits in which R/S interventions were used increased by 9.5% (833 instances; χ²(1) = 185.52, p < .001) during the first year of COVID (Table 1 and Fig 2). This is further confirmed by binary logistic regression results indicating that patients presenting to Ontario EDs during the first year of COVID were 23% more likely to experience an R/S event than those presenting the year prior (OR = 1.23, p < .001, 95% CI [1.19, 1.27]). This observed increase in the prevalence of R/S intervention use was comparable across both restraint (physical/mechanical/chair; 9.6% increase) and seclusion (9.1% increase) intervention methods (Table 1 and Fig 3).

thumbnail
Fig 2. Number of ED visits by R/S event occurrence.

Number of ED visits in Ontario before (2019) and after (2020) the onset of the COVID-19 pandemic by R/S event occurrence (bar; right axis) with corresponding percent change from pre-COVID (2019) levels (line; left axis). ED = emergency department, R/S = restraint and seclusion intervention.

https://doi.org/10.1371/journal.pone.0302164.g002

thumbnail
Fig 3. Number of ED visits by type of R/S event occurrence.

Number of ED visits in Ontario before (2019) and after (2020) the onset of the COVID-19 pandemic by type of R/S event occurred (bar; right axis) with corresponding percent change from pre-COVID (2019) levels (line; left axis). ED = emergency department, R/S = restraint and seclusion intervention.

https://doi.org/10.1371/journal.pone.0302164.g003

Factors associated with COVID-related changes in the use of R/S interventions

Registration month.

There was a significant interaction between the month and the year of registration (Wald χ² (11) = 109.48, p < .001), suggesting that the onset of the COVID pandemic had a substantially different effect on the likelihood of an R/S event occurring depending on the month in which a patient visited an ED. Upon exploration of predictor-level interaction effects, a clear pattern of changes in R/S probability emerged primarily centered on the onset of the COVID pandemic in Ontario (Table 1 and Fig 4).

thumbnail
Fig 4. Month of ED visit.

Percent of ED visits by registration month in which an R/S event occurred before (2019) and after (2020) the onset of the COVID-19 pandemic (bar; right axis) with corresponding changes R/S probability between 2019 and 2020 (line; left axis). ED = emergency department, R/S = restraint and seclusion intervention.

https://doi.org/10.1371/journal.pone.0302164.g004

Most notably, there was a dramatic increase in the probability of an R/S event at the start of the first wave of the COVID pandemic in Ontario, beginning with a 3.6% increase in April 2020, followed by a decreasing trend in the magnitude of the R/S probability change in May (2.5%), and June (1.4%) of 2020, with R/S probability returning to levels comparable to those before the onset of COVID by July of 2020 (> 1% increase in R/S probability; Table 1 and Fig 4). Another period of increased likelihood of R/S was observed during Ontario’s second wave of the COVID pandemic, albeit to a much lesser degree than was seen during the first wave. Specifically, the likelihood of an R/S event began to increase again beginning in September 2020 (the beginning of the second wave) and plateaued at a 1% increase from pre-COVID levels from November 2020 to February 2021 (Table 1 and Fig 4).

Main problem diagnosis.

The type of SU/MH concern (main problem diagnosis) a patient presented with significantly interacted with patient registration year (Wald χ² (9) = 30.35, p < .001), suggesting that the onset of the COVID pandemic impacted the probability of experiencing an R/S event differently depending on a patient’s main problem diagnosis. Further exploration revealed that there was a general increase in the probability of an R/S event across all diagnostic categories from 2019 to 2020 (range = 0.7% - 21.3%), and it is only the magnitude of this increase that varied across diagnostic categories (Table 1 and Fig 5).

thumbnail
Fig 5. Main problem diagnosis.

Percent of ED visits by main problem diagnosis in which an R/S event occurred before (2019) and after (2020) the onset of the COVID-19 pandemic (bar; right axis) with corresponding changes R/S probability between 2019 and 2020 (line; left axis). ED = emergency department, R/S = restraint and seclusion intervention.

https://doi.org/10.1371/journal.pone.0302164.g005

Patients with a diagnosis of dementia saw the greatest increase of 21.3% in the likelihood of experiencing an R/S event after COVID onset, followed by patients diagnosed with a psychotic disorder or polysubstance abuse, who both showed an increase of 17.7% in their likelihood of experiencing an R/S event (Table 1 and Fig 5). Individuals diagnosed with a personality disorder saw a moderate 13.3% increase in R/S probability after COVID onset, while an increase of approximately 10% in R/S probability was found for patients diagnosed with cannabinoid abuse, a mood disorder, or other mental health disorder not otherwise specified. Finally, patients diagnosed with alcohol abuse (0.7% increase), opioid abuse (5.4% increase), or an anxiety disorder (3.4% increase) saw the smallest increases in the probability of experiencing an R/S event from pre-COVID levels.

Discussion

The present study aimed to examine the association between temporal and clinical factors and changes in the use of R/S interventions in Ontario EDs during the COVID pandemic as an indicator of broader changes in the quality of care and patient experiences during this time. To this end, we first wanted to establish whether the onset of COVID affected ED access and the use of R/S interventions during service provision in Ontario EDs. We found that there were approximately 17,000 fewer visits to Ontario EDs for MH/SU concerns after the onset of the pandemic, a decrease of almost 10% from pre-COVID levels. Notably, despite there being fewer ED visits during the first year of the pandemic, the number of visits where an R/S event occurred increased by almost 10%, which translated to 833 more visits in which the patient was restrained or secluded during service provision, which is consistent with previous research exploring COVID-related changes in R/S intervention use.

Further underscoring the fact that this observed increase in R/S intervention use was related to the pandemic onset, the greatest increase in R/S risk was seen for patients who accessed Ontario EDs during the first few months of the first wave of the pandemic (April–June 2020). The pandemic was officially declared a public health emergency in Ontario on March 17, 2020, suggesting that the observed spike in the probability of R/S intervention use aligns with this declaration and the resulting impact on the public and healthcare system. We suggest that the combination of staffing resource shortages, and strict infection prevention protocols likely prevented staff from effectively employing traditional de-escalation methods and less coercive R/S alternatives, such as 1-to-1 patient supervision. Consistent with this interpretation, we also found that the prevalence of R/S use returned to comparable levels by the end of the first wave of infection, suggesting that, as resources and staffing stabilized, the healthcare system was able to adapt and mitigate factors associated with the temporary increase in the use of R/S interventions.

Even more dramatic than the observed temporal effects of COVID was the finding that the risk of experiencing an R/S event doubled for almost all patients who presented to Ontario EDs with primary complaints associated with MH/SU concerns after the onset of COVID, regardless of the specific disorder. This further supports the suggestion that increases in R/S intervention use during COVID were a function not only of the exacerbation of psychiatric and behavioural symptoms specific to certain disorders but also the systemic issues related to health care service provision described above, namely, the availability of relevant resources. In addition to increasing the likelihood that patients with MH/SU-related concerns had to turn to ED services during COVID, the lack of alternative resources may have also led patients to delay seeking treatment, resulting in significantly greater symptom severity and in turn, R/S risk when the patient did seek care. Notably, the probability of R/S use nearly tripled for patients presenting with MH/SU concerns that were already associated with increased R/S risk prior to COVID onset, namely psychosis, personality disorder, dementia, and substance abuse. Arguably, these patients are also more likely to have had difficulty complying with strict infection prevention protocols during service provision due to the cognitive and behavioural symptoms specific to these disorders. This in turn may have contributed to the disproportionate increase in R/S intervention use we observed, as the use of physical restraint or patient seclusion may have been necessary to minimize infection risk in non-compliant patients.

Limitations

The most notable limitations of the present study come from the nature of the sample data used to conduct our analyses. As our present analyses were restricted to data from ED visits in which R/S intervention use reporting was mandatory and complete, this limited our sample to patients who presented with primary complaints associated with an MH/SU condition. In other words, if a patient did not present with an MH/SU, they were not captured in our dataset. While this prevents us from drawing broader conclusions regarding COVID-related changes in R/S intervention use for patients with other primary concerns, it is also a realistic "snapshot" of the use of R/S interventions in an ED setting. Specifically, this population is generally at greater risk of experiencing restraint and needing emergency care, making them an important (and logical) patient population to focus on when trying to understand the impact of COVID on the use of R/S interventions. Similarly, because individual cases in the present data set represent the information collected during a single visit to an Ontario ED, the present sample is, by definition, not independent at the subject level in the traditional sense. In other words, there are undoubtedly patients in our sample who presented to an Ontario ED multiple times throughout the fiscal year, resulting in an overrepresentation of certain patient demographics in the sense of the "average" patient accessing ED services.

Finally, the scope of the present study was restricted by the fact that the available data was necessarily limited to the variables collected by the data reporting agency. For example, while it would be informative, the NACRS data collection guidleines do not currently require manditory reporting of the specific clinical symptoms reported at the time of presentation to the ED or the specific reason for restraint use (e.g., aggressive behaviour, fall risk, treatment compliance, etc.). As such, we cannot draw any conclusions about whether the COVID-related increase in restraint use was associated with an increase of specific behavioural concerns, which may be more prominent among certain patient populations.

Future directions

This study is just an initial step toward understanding the underlying issues that contributed to the increased use of R/S interventions among patients presenting to EDs with MH/SU-related concerns. Naturally, more research into the factors associated with changes in R/S intervention use due to the COVID pandemic is needed to fully understand how such events impact patient care. A better understanding of the underlying factors driving the differences in the likelihood of an R/S event across different patient populations and treatment settings is of particular importance, not only to identify additional exacerbating factors, but also mitigating factors that effectively reduced R/S risk under similar circumstances. In line with this, the synthesis of the research into the factors associated with increased R/S intervention use is equally important, as it has the potential to be translated into valuable improvements to existing policies and practices related to the use of R/S interventions. Similarly, continued attention to education and training regarding the use of R/S interventions is equally important, with particular emphasis on appropriate use and practical alternatives to coercive methods. For example, in response to the COVID pandemic, there is a clear need to develop strategies to minimize the need to use such methods as a form of infection prevention among vulnerable populations that struggle with treatment compliance.

In particular, as suggested above, the observed increase in R/S intervention use in the present study is likely not only due to an increase in psychiatric symptom severity but also because of the overall strain on the healthcare systems leading to a lack of resources. Therefore, efforts to prevent similar increases in the number of R/S events during future major public health crises should focus on non-patient-related contextual factors that are likely to be impacted, such as access to non-emergent psychological services and substance abuse programming. One of the outcomes of the pandemic was the advent and refinement of telehealth programs that made non-emergent healthcare services much more accessible while minimizing infection risk. This now-existing infrastructure may help mitigate similar situations during future public health crises by allowing easier and earlier access to services specifically intended to address concerns related to MH/SU issues before they require emergency care and the use of R/S intervention methods. Having said this, the public health system cannot hope to rely solely on telehealth alternatives and should develop appropriate emergency response plans to deploy and allocate resources with the knowledge that major public health crises can have a disproportionately negative impact on the experience of already vulnerable patient populations, as well as patients who may be experiencing MH/SU issue for the first time due to the unique stressors associated with major public health crises, such as COVID.

Conclusions

The results of the present study provide evidence that the use of R/S interventions in Ontario EDs increased substantially among patients presenting with MH/SU concerns after the onset of COVID, despite a decrease in the number of ED visits during the same period. Further underscoring the detrimental effect of COVID on the Ontario health care system, the observed increase in R/S intervention use was most prominent during the first few months after the public health emergency declaration in Ontario, when resources were under the most significant strain and uncertainty surrounding the virus was at its highest. Finally, we demonstrated that patients presenting to Ontario EDs with MH/SU-related concerns were at a substantially increased risk of experiencing an R/S event during the first year of the pandemic, regardless of the specific nature of their presenting concern, but that this effect was most pronounced for patients with MH/SU concerns traditionally associated with increased risk of R/S intervention use.

Taken together, the findings of the present strongly support the conclusion that the observed increase in R/S intervention use in Ontario EDs may be a result of the general state of upheaval in the Ontario healthcare system caused by the COVID pandemic. In context with the existing literature, the results of this study have the potential to further our understanding of COVID-related changes in the presentation of MH/SU issues in ED facilities, as well as how the healthcare system responded to these changes during the pandemic. Furthermore, this knowledge has the potential to inform and guide improvements to existing policies and procedures related to the use of R/S interventions to minimize the inherent risk to both patients and staff.

Supporting information

S1 Table. Binary logistic regression model statistics.

https://doi.org/10.1371/journal.pone.0302164.s001

(PDF)

S2 Table. Regression equation coefficients (B-weights) and variable values used to calculate R/S probability.

https://doi.org/10.1371/journal.pone.0302164.s002

(PDF)

References

  1. 1. Office of the Premier of Ontario. Ontario enacts declaration of emergency to protect the public. Ontario Newsroom. 2020 March 17 [cited 2023 March 17]. Available from: https://news.ontario.ca/en/release/56356/ontario-enacts-declaration-of-emergency-to-protect-the-public
  2. 2. Androutsou L, Latsou D, Geitona M. Health systems’ challenges and responses for recovery in the pre and post COVID-19 era. Journal of Service Science and Management. 2021;14(4): 444–460.
  3. 3. Dudevich A, Frood J. Impact of the COVID-19 pandemic on health system use in Canada. Healthc Q. 2021;24(2): 12–14. pmid:34297658
  4. 4. Rennert-May E, Leal J, Thanh NX, Lang E, Dowling S, Manns B, et al. The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study. PLoS One. 2021;16(6): e0252441. pmid:34061888
  5. 5. Desson Z, Weller E, McMeekin P, & Ammi M. An analysis of the policy responses to the COVID-19 pandemic in France, Belgium, and Canada. Health Policy and Technology. 2020;9(4): 430–446. pmid:33520640
  6. 6. Sandhu HS, Smith RW, Jarvis T, O’Neill M, Di Ruggiero E, Schwartz R, et al. Early impacts of the COVID-19 pandemic on public health systems and practice in 3 Canadian provinces from the perspective of public health leaders: A qualitative study. Journal of Public Health Management and Practice. 2022;28(6): 702–711. pmid:36027605
  7. 7. Polisena J, Ospina M, Sanni O, Matenchuk B, Livergant R, Amjad S, et al. Public health measures to reduce the risk of SARS-CoV-2 transmission in Canada during the early days of the COVID-19 pandemic: A scoping review. BMJ Open. 2021;11(3): e046177. pmid:33687956
  8. 8. Chief Public Health Officer of Canada. From risk to resilience: An equity approach to COVID-19. Public Health Agency of Canada. 2020 [cited 2023 March 24]. Available from: https://www.canada.ca/content/dam/phac-aspc/documents/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/from-risk-resilience-equity-approach-covid-19/cpho-covid-report-eng.pdf
  9. 9. Dunlop A, Lokuge B, Masters D, Sequeira M, Saul P, Dunlop G, et al. Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020;17(1): 1–7.
  10. 10. Barten DG, Latten GH, Van Osch FH. Reduced emergency department utilization during the early phase of the COVID-19 pandemic: Viral fear or lockdown effect?. Disaster Medicine and Public Health Preparedness. 2022;16(1): 36–39. pmid:32782063
  11. 11. Wong LE, Hawkins JE, Langness S, Murrell KL, Iris P, & Sammann A. Where are all the patients? Addressing COVID-19 fear to encourage sick patients to seek emergency care. NEJM Catalyst. 2020;1(3): 1–12.
  12. 12. Root ED, Slavova S, LaRochelle M, Feaster DJ, Villani J, Defiore-Hyrmer J, et al. The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic. Drug and Alcohol Dependence. 2021;228: 108977. pmid:34598100
  13. 13. Diaz-Granados N, Georgiades K, Boyle MH. Regional and individual influences on use of mental health services in Canada. The Canadian Journal of Psychiatry. 2010;55(1): 9–20. pmid:20113539
  14. 14. Moe J, Bailey AL, Oland R, Levesque L, & Murray H. Defining, quantifying, and characterizing adult frequent users of a suburban Canadian emergency department. CJEM. 2013;15(4): 214–226. pmid:23777993
  15. 15. Saunders NR, Gill PJ, Holder L, Vigod S, Kurdyak P, Gandhi S, et al. Use of the emergency department as a first point of contact for mental health care by immigrant youth in Canada: A population-based study. CMAJ. 2018;190(40): E1183–E1191. pmid:30301742
  16. 16. Munich J, Dennett L, Swainson J, Greenshaw AJ, & Hayward J. Impact of pandemics/epidemics on emergency department utilization for mental health and substance use: A rapid review. Front Psychiatry. 2021;12: 615000. pmid:33716818
  17. 17. Gómez-Ramiro M, Fico G, Anmella G, Vázquez M, Sagué-Vilavella M, Hidalgo-Mazzei D. Changing trends in psychiatric emergency service admissions during the COVID-19 outbreak: Report from a worldwide epicentre. J Affect Disord. 2021;282: 26–32. pmid:33387743
  18. 18. Ham E, Hilton NZ, Crawford J, & Kim S. The effect of the COVID-19 pandemic on psychiatric inpatient services in Ontario: A cross-sectional comparison of inpatient admissions and acuity during pre-restrictions, restrictions and post-restrictions. CMAJ. Forthcoming.
  19. 19. Avena NM, Simkus J, Lewandowski A, Gold MS, & Potenza MN. Substance use disorders and behavioral addictions during the COVID-19 pandemic and COVID-19-related restrictions. Front Psychiatry. 2021;12: 653674. pmid:33935838
  20. 20. Saunders NR, Toulany A, Deb B, Strauss R, Vigod SN, Guttmann A, et al. Acute mental health service use following onset of the COVID-19 pandemic in Ontario, Canada: A trend analysis. CMAJ Open. 2021;9(4): E988–E997. pmid:34785528
  21. 21. Holland KM, Jones C, Vivolo-Kantor AM, Idaikkadar N, Zwald M, Hoots B, et al. Trends in US emergency department visits for mental health, overdose, and violence outcomes before and during the COVID-19 pandemic. JAMA Psychiatry. 2021;78(4): 372–379. pmid:33533876
  22. 22. Stroever S, Brett C, Michael K, & Petrini J. Emergency department utilization for mental health conditions before and after the COVID-19 outbreak. Am J Emerg Med. 2021;47: 164–168. pmid:33813148
  23. 23. Anderson KN, Radhakrishnan L, Lane RI, Sheppard M, DeVies J, Azondekon R, et al. Changes and inequities in adult mental health-related emergency department visits during the COVID-19 pandemic in the US. JAMA Psychiatry. 2022;79(5): 475–485. pmid:35293958
  24. 24. Torales J, O’Higgins M, Castaldelli-Maia JM, & Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020;66(4): 317–320. pmid:32233719
  25. 25. Roberts A, Rogers J, Mason R, Siriwardena AN, Hogue T, Whitley GA, et al. Alcohol and other substance use during the COVID-19 pandemic: A systematic review. Drug and Alcohol Dependence. 2021;229: 109150. pmid:34749198
  26. 26. Venkatesh AK, Janke AT, Kinsman J, Rothenberg C, Goyal P, Malicki C, et al. Emergency department utilization for substance use disorders and mental health conditions during COVID-19. PLoS One. 2022;17(1): e0262136. pmid:35025921
  27. 27. Waibel S, Wu WL, Smith M, Johnson L, & Janke RD. Selection of pediatric mental health quality measures for health system improvement in British Columbia based on a modified Delphi approach. Front Pediatr. 2022;10: 866391. pmid:35874563
  28. 28. Thomann S, Hahn S, Schmitt KU, Barbezat I, Siegrist-Dreier S, & Richter D. Restraint use as a quality indicator for the hospital setting: A secondary data analysis. Swiss Med Wkly. 2021;151: 1–10. pmid:34908384
  29. 29. Balfour ME, Tanner K, Jurica PJ, Rhoads R, & Carson CA. Crisis Reliability Indicators Supporting Emergency Services (CRISES): A framework for developing performance measures for behavioral health crisis and psychiatric emergency programs. Community Ment Health J. 2016;52: 1–9. pmid:26420672
  30. 30. Wale JB, Belkin GS, & Moon R. Reducing the use of seclusion and restraint in psychiatric emergency and adult inpatient services—improving patient-centered care. Perm J. 2011;15(2): 57–62. pmid:21841927
  31. 31. Gunawardena R, Smithard DG. The attitudes towards the use of restraint and restrictive intervention amongst healthcare staff on acute medical and frailty wards–A brief literature review. Geriatrics. 2019;4(3): 50. pmid:31487923
  32. 32. Wong AH, Ray JM, Rosenberg A, Crispino L, Parker J, McVaney C, et al. Experiences of individuals who were physically restrained in the emergency department. JAMA Netw Open. 2020;3(1): e1919381. pmid:31977058
  33. 33. Martin K, Arbour S, McGregor C, & Rice M. Silver linings: Observed reductions in aggression and use of restraints and seclusion in psychiatric inpatient care during COVID‐19. Journal of Psychiatric and Mental Health Nursing. 2022;29(2): 381–385. pmid:33704877
  34. 34. Feeney L, Bonner N, & McAndrew J. Restrictive interventions on a psychiatric admission ward before and after COVID-19. Ir J Psychol Med. 2023;40: 430–436. pmid:35388786
  35. 35. Guzman-Parra J, Gómez-Sánchez-Lafuente C, Medina MG, Aguilera-Serrano C, Moreno-Küstner B, Hurtado-Melero V, et al. COVID-19 pandemic in a mental health ward: Inpatient admissions, use of mechanical restraint and aggressions. Res Sq. 2022.
  36. 36. Okuno T, Itoshima H, Shin JH, Morishita T, Kunisawa S, & Imanaka Y. Physical restraint of dementia patients in acute care hospitals during the COVID-19 pandemic: A cohort analysis in Japan. PLoS One. 2021;16(11): e0260446. pmid:34807945
  37. 37. Jones A, Goodarzi Z, Lee J, Norman R, Wong E, Dasgupta M, et al. Chemical and physical restraint use during acute care hospitalization of older adults: A retrospective cohort study and time series analysis. PLoS One. 2022;17(10): e0276504. pmid:36288382
  38. 38. Leith T, Brieger K, Malas N, McCaffery H, Monroe K, Kullgren KA, et al. Increased prevalence and severity of psychiatric illness in hospitalized youth during COVID-19. Clinical Child Psychology and Psychiatry. 2022;27(3): 804–812. pmid:35236147
  39. 39. Dror C, Hertz-Palmor N, Barzilai Y, Gila S, Tali BZ, Alex G, et al. Youth psychiatric hospitalization in Israel during COVID-19: A multi-center study. Int J Environ Res Public Health. 2022;19(16), 9870. pmid:36011509
  40. 40. Flammer E, Eisele F, Hirsch S, & Steinert T. Increase in coercive measures in psychiatric hospitals in Germany during the COVID-19 pandemic. PLoS ONE. 2022;17(8): e0264046. pmid:36044407
  41. 41. Wullschleger A, Gonçalves L, Royston M, Sentissi O, Ambrosetti J, Kaiser S, et al. Admissions to psychiatric inpatient services and use of coercive measures in 2020 in a Swiss psychiatric department: An interrupted time-series analysis. PLoS ONE. 2023;18(7): e0289310. pmid:37498908
  42. 42. Aluh DO, Santos-Dias M, Silva M, Pedrosa B, Grigaitė U, Silva RC, et al. Contextual factors influencing the use of coercive measures in Portuguese mental health care. Int J Law Psychiatry. 2023;90: 101918. pmid:37541138
  43. 43. De Berardis D, Ventriglio A, Fornaro M, Vellante F, Martinotti G, Fraticelli S, et al. Overcoming the use of mechanical restraints in psychiatry: A new challenge in the everyday clinical practice at the time of COVID-19. J Clin Med. 2020;9(11), 3774. pmid:33238428
  44. 44. Canadian Institute for Health Information. CIHI Portal—NACRS Metadata Dictionary. Ottawa, ON: CIHI; 2020. https://www.cihi.ca/en/national-ambulatory-care-reporting-system-metadata-nacrs
  45. 45. Canadian Institute for Health Information. NACRS Abstracting Manual, 2018–2019. Ottawa, ON: CIHI; 2018.
  46. 46. Canadian Institute for Health Information. Canadian Coding Standards for Version 2022 ICD-10-CA and CCI. Ottawa, ON: CIHI; 2022.
  47. 47. World Health Organization. Tenth revision of the International Classification of Diseases Chapter V: Mental, behavioural and developmental disorders, clinical descriptions and diagnostic guidelines (No. WHO/MNH/MEP/87.1, rev. 2.) [Unpublished]. Geneva, Switzerland: WHO; 1988.
  48. 48. IBM Corp. IBM SPSS Statistics for Windows (Version 28.0). Armonk, NY: IBM Corp; 2021. Available from: https://www.ibm.com/spss?lnk=flatitem
  49. 49. Microsoft Corporation. Microsoft Excel (Version 16.0). Redmond, WA: Microsoft Corp; 2016. Available from: https://office.microsoft.com/excel